MVIR:STO
Medivir AB
1,55ย SEK
arrow_downward
โ1,90%(โ0,030) 1D
7. lis, 14:32:35 GMT+2 · SEK
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvaลพnijih uvida za MVIR...
Otvori
1,56ย SEK
Najviลกa
1,58ย SEK
Najniลพa
1,53ย SEK
Trลพ. kap.
1,03ย mlr.
Prosj. kol.
1,71ย mil.
Koliฤina
847,70ย tis.
52-tjed. najviลกa
2,88ย SEK
52-tjed. najniลพa
0,34ย SEK
EPS
โ0,37ย SEK
Dionice u optjecaju
624,18ย mil.
Broj djelatnika
6
Otvori
1,56ย SEK
Najviลกa
1,58ย SEK
Najniลพa
1,53ย SEK
Trลพ. kap.
1,03ย mlr.
Prosj. kol.
1,71ย mil.
Koliฤina
847,70ย tis.
52-tjed. najviลกa
2,88ย SEK
52-tjed. najniลพa
0,34ย SEK
EPS
โ0,37ย SEK
Dionice u optjecaju
624,18ย mil.
Broj djelatnika
6
Vijesti
Iz web-izvora i od partnera za vijesti
Naslovi.net
·
prije 1 dan
Wall Street: Nasdaq na novom rekordu
Lider Media
·
prije 5 sati
Na Wall Streetu rekord S&P 500 indeksa
Financije.hr
·
prije 6 sati
S&P 500 i Nasdaq na rekordnim razinama, azijske burze pale
PR Newswire
·
prije 22 minute
Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA Compliance
Profil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Medivir AB โ informacije
Glavni izvrลกni direktorChristine Lind
Zaposlenici6
Osnovano1988
Sjediลกte-
Sektor-
Web-lokacijamedivir.com